Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Fennec Pharmaceuticals stock

Learn how to easily invest in Fennec Pharmaceuticals stock.

Fennec Pharmaceuticals Inc is a biotechnology business based in the US. Fennec Pharmaceuticals shares (FENC) are listed on the NASDAQ and all prices are listed in US Dollars. Fennec Pharmaceuticals employs 9 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Fennec Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – FENC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Fennec Pharmaceuticals stock price (NASDAQ: FENC)

Use our graph to track the performance of FENC stocks over time.

Fennec Pharmaceuticals shares at a glance

Information last updated 2022-01-17.
Latest market close$4.60
52-week range$3.82 - $10.08
50-day moving average $6.03
200-day moving average $7.08
Wall St. target price$10.80
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.63

Buy Fennec Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs
$0 per year
Get a free stock valued up to $3500
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Fennec Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Fennec Pharmaceuticals price performance over time

Historical closes compared with the close of $4.6 from 2022-01-18

1 week (2022-01-12) -3.06%
1 month (2021-12-17) 12.75%
3 months (2021-10-19) -48.26%
6 months (2021-07-19) -29.66%
1 year (2021-01-19) -41.85%
2 years (2020-01-17) -25.57%
3 years (2019-01-18) 6.98
5 years (2017-01-19) 135.90%

Fennec Pharmaceuticals financials

Revenue TTM $170,000
Gross profit TTM $170,000
Return on assets TTM -34.04%
Return on equity TTM -64.37%
Profit margin 0%
Book value $0.73
Market capitalisation $120.4 million

TTM: trailing 12 months

Fennec Pharmaceuticals share dividends

We're not expecting Fennec Pharmaceuticals to pay a dividend over the next 12 months.

Have Fennec Pharmaceuticals's shares ever split?

Fennec Pharmaceuticals's shares were split on a 1:3 basis on 4 September 2014. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Fennec Pharmaceuticals shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Fennec Pharmaceuticals shares which in turn could have impacted Fennec Pharmaceuticals's share price.

Fennec Pharmaceuticals share price volatility

Over the last 12 months, Fennec Pharmaceuticals's shares have ranged in value from as little as $3.822 up to $10.078. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fennec Pharmaceuticals's is 0.0588. This would suggest that Fennec Pharmaceuticals's shares are less volatile than average (for this exchange).

Fennec Pharmaceuticals overview

Fennec Pharmaceuticals Inc. , a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc.

Frequently asked questions

What percentage of Fennec Pharmaceuticals is owned by insiders or institutions?
Currently 16.942% of Fennec Pharmaceuticals shares are held by insiders and 44.821% by institutions.
How many people work for Fennec Pharmaceuticals?
Latest data suggests 9 work at Fennec Pharmaceuticals.
When does the fiscal year end for Fennec Pharmaceuticals?
Fennec Pharmaceuticals's fiscal year ends in December.
Where is Fennec Pharmaceuticals based?
Fennec Pharmaceuticals's address is: 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709
What is Fennec Pharmaceuticals's ISIN number?
Fennec Pharmaceuticals's international securities identification number is: CA31447P1009
What is Fennec Pharmaceuticals's CUSIP number?
Fennec Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00686R101

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site